Canopy Growth Corp. (TSX: WEED / NASDAQ: CGC) will relaunch its Tweed brand in the German medical market, alongside the introduction of three cannabis strains developed by MTL Cannabis Corp., a wholly-owned subsidiary of the company. The dual milestone represents the company’s first international product release following its recent acquisition of MTL. The relaunch comes as Germany’s medical cannabis market continues to expand rapidly, approaching $1 billion in annual value in 2025. The MTL acquisition has enhanced Canopy Growth’s capacity to meet rising demand in key international markets, including Germany, while reintroducing a brand that physicians and patients have come to trust.
Click here for the full story.
Top cannabis news stories
1 | Decibel reports Q1 2026 results: Quarterly revenue grows 41 per cent year-over-year to C$30 million, issues Q2 2026 guidance
2 | Curaleaf announces 1-for-3 reverse stock split in preparation for U.S. stock exchange uplisting
3 | Herbal Dispatch obtains Export Development Canada insurance to accelerate international growth
Top Cannabis Stocks May 22 to May 28, 2026
1. T.CURA | 6,587 views | Curaleaf Holdings Inc.
2. T.LABS | 3,672 views | Medipharm Labs Corp.
3. T.TLRY | 2,323 views | Tilray Brands Inc.
4. T.OGI | 704 views | Organigram Global Inc.
5. C.BLO | 697 views | Cannabix Technologies Inc.
6. C.TGIF | 290 views | 1933 Industries Inc.
